SPNS2 and non-small cell lung carcinoma: In a first study, SPNS2 was downregulated in a small cohort of human lung tumors and overexpression of SPNS2 in non-small cell lung carcinoma cells led to increased S1P secretion, decreased cell migration, and induction of apoptosis [79].